tbuckley/cabot-search huggingface dataset:
Risk Factors Associated with in-Hospital COVID-19 Mortality in a Public Hospital in Brazil
Authors: Ana Carla Franklin Braga, Juliana Borges Coelho, Angélica Maria Rodrigues França, Alessa Cléa Rebouças Holanda, Filipe Bittencourt Paz de Sousa, Sâmya Di Paula Alves Ferreira Sampaio, Nádia Cristina De Sousa Misael, Fernando Sergio Blumm Ferreira, Flávia Dias Xavier
Journal: Blood (2022)
Orelabrutinib, Rituximab, and High-Dose Methotrexate (HD-MTX) in Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL): A Retrospective Analysis on Efficacy, Safety, and Biomarker
Authors: Shihua Zhao, Yao Liu, Zunmin Zhu, Jianxia He, Lihong Liu, Xiaobo Wang, Yuxia Zhao, Chongling Hu, Xiaoli Yuan, Sijun Bai, Ye Geng, Wenrong Huang
Journal: Blood (2022)
Single-Cell Analysis of Human Clonal Hematopoiesis Identifies Distinct Impact of <i>DNMT3A</i> and <i>TET2</i> mutations on Hematopoietic Differentiation
Authors: Niels Asger Jakobsen, Sven Turkalj, Bilyana Stoilova, Marlen Metzner, Rachel Moore, Batchimeg Usukhbayar, Mirian Angulo Salazar, Alison Kennedy, Simon Newman, Benjamin Kendrick, Adrian Taylor, Rasheed Afinowi-Luitz, Roger Gundle, Bridget Watkins, Kim Wheway, Debra Beazley, Andrew Carr, Paresh Vyas
Journal: Blood (2022)
Changes of Transcriptomic Landscape in Blasts of Responding and Refractory Acute Myeloid Leukemia Patients after Chemotherapy
Authors: Ela Cerovska, Cyril Salek, David Kundrat, Zdenek Krejcik, Monika Belickova, Jaroslav Cermak, Hana Remesova
Journal: Blood (2022)
Three-Year Update from the Optic Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib
Authors: Jorge E. Cortes, Michael W. Deininger, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Christine Rojas, Anna Turkina, Lori Maness, Moshe Talpaz, Michael Mauro, Vickie Lu, Alexander Vorog, Jane F. Apperley
Journal: Blood (2022)
Ongoing Risk of Unrelated Donors Testing Positive for COVID-19 Following Medical Clearance and Impact on Operations: A Report from the National Marrow Donor Program
Authors: Heather E Stefanski, Jennifer Novakovich, Jennifer Newman, Christian Snyder, Meghann Cody, Jason Oakes, Amy Nielson, Jeffery Auletta, John P. Miller, Steven M Devine
Journal: Blood (2022)
Subclinical Minute <i>FLT3</i>-ITD Clone Can be Detected in Clinically <i>FLT3</i>-ITD-Negative Acute Myeloid Leukemia
Authors: Shota Yokoyama, Masahiro Onozawa, Shota Yoshida, Naoki Miyashita, Hiroyuki Kimura, Shogo Takahashi, Toshihiro Matsukawa, Shinichi Fujisawa, Kosuke Miki, Daisuke Hidaka, Junichi Hashiguchi, Kentaro Wakasa, Makoto Ibata, Yukari Takeda, Akio Shigematsu, Katsuya Fujimoto, Yutaka Tsutsumi, Akio Mori, Toshimichi Ishihara, Yasutaka Kakinoki, Takeshi Kondo, Takanori Teshima
Journal: Blood (2022)
Long-Term Safety and Efficacy of Pegcetacoplan Treatment in Adults with Paroxysmal Nocturnal Hemoglobinuria
Authors: Christopher J. Patriquin, Andrija Bogdanovic, Morag Griffin, Richard Kelly, Jaroslaw P. Maciejewski, Brian Mulherin, Régis Peffault de Latour, Alexander Roeth, Veena Selvaratnam, Jeffrey Szer, Jessica Savage, Regina Horneff, Lisa Tan, Michael Yeh, Jens Panse
Journal: Blood (2022)
Initiating First-Line (1L) Ibrutinib (Ibr) in Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Improves Overall Survival (OS) Outcomes to Rates Approximating an Age-Matched Population of ≥65 Years
Authors: Paolo Ghia, Carolyn Owen, Jacqueline C. Barrientos, Paul M. Barr, Anthony R. Mato, Chunxue Shi, Anita Szoke, Chris Abbazio, Gabriel S. Krigsfeld, Jan A. Burger
Journal: Blood (2022)
A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study
Authors: Herve Ghesquieres, Youenn Drouet, Susan L. Slager, Franck Morschhauser, Sara Galimberti, Dennis P. Robinson, Emilie Thomas, Anne J. Novak, Luc Xerri, Stefano Luminari, Aurelie Verney, Camille Laurent, Lisa M. Rimsza, Thomas M. Habermann, Massimo Federico, Brian K. Link, Gilles Salles, James R. Cerhan
Journal: Blood (2022)
Safety and Tolerability of Pirtobrutinib Monotherapy in Patients with B-Cell Malignancies Who Were Previously Intolerant to a Covalent BTK Inhibitor: Results from the Phase 1/2 BRUIN Study
Authors: Nirav N. Shah, Michael L. Wang, Jennifer R. Brown, Krish Patel, Jennifer A. Woyach, William G. Wierda, Chaitra S. Ujjani, Toby A. Eyre, Pier Luigi Zinzani, Alvaro J. Alencar, Thomas Gastinne, Paolo Ghia, Nicole Lamanna, Marc Hoffmann, Manish R. Patel, Ian W. Flinn, James N. Gerson, Shuo Ma, Catherine C. Coombs, Chan Y. Cheah, Ewa Lech-Marańda, Bita Fakhri, Won-Seog Kim, Minal A. Barve, Jonathon B. Cohen, Wojciech Jurczak, Talha Munir, Meghan C. Thompson, Lindsey E. Roeker, Katherine Bao, Nicholas A. Cangemi, Jennifer F. Kherani, Richard A. Walgren, Hongmei Han, Amy S. Ruppert, Anthony R. Mato
Journal: Blood (2022)
Allogeneic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T Cell Malignancies
Authors: Yinqiang Zhang, Chenggong Li, Huiwen Jiang, Wenjing Luo, Mengyi Du, Fen Zhou, Lu Tang, Jianghua Wu, Qiuzhe Wei, Cong Lu, Haiming Kou, Di Wu, Chang Alex H, Heng Mei, Yu Hu
Journal: Blood (2022)
Cancer Chemotherapy Accelerates the Loss of Clonal Diversity in Hematopoietic Stem Cells and Promotes the Convergent Evolution of Therapy-Related Clonal Hematopoiesis
Authors: Hidetaka Uryu, Koichi Saeki, Jyoti Nangalia, Michael Spencer Chapman, Li Zhao, Joanne I. Hsu, Carlos E. Bueso-Ramos, Shujuan Chen, Hui Yang, Hagop Kantarjian, Courtney D. DiNardo, Naval Daver, Simona Colla, Irene Ganan-Gomez, Jianhua Zhang, Xingzhi Song, Erika Thompson, Hongli Tang, Robert Z. Orlowski, Richard E Champlin, Muzaffar H Qazilbash, Elizabeth J Shpall, Guillermo Garcia-Manero, Hiroshi Haeno, Koichi Takahashi, Andrew Futreal
Journal: Blood (2022)
Mechanistic Study of Wee1 Kinase Inhibition with AZD1775 Exposes Drug Targetable Vulnerabilities in Acute B-Lymphoblastic Leukemia
Authors: Alena Malyukova, Mari Lahnalampi, Ton Falqués, Petri Pölönen, Mikko Sipola, Juha Mehtonen, Susanna Teppo, Johanna Viiliäinen, Olli Lohi, Anna Hagstroem-Andersson, Merja Heinäniemi, Olle Sangfelt
Journal: Blood (2022)
The Addition of Romidepsin to CHOEP and High-Dose Chemotherapy Plus Stem Cell Transplantation Did Not Ameliorate the Outcome of Untreated Angioimmunoblastic T-Cell or Follicular T-Helper Lymphoma: Subgroup Analysis of Phase II FIL-PTCL13 Study
Authors: Annalisa Chiappella, Anna Dodero, Andrea Evangelista, Alessandro Re, Lorella Orsucci, Sara Veronica Usai, Claudia Castellino, Vittorio Stefoni, Antonio Pinto, Manuela Zanni, Rosanna Ciancia, Chiara Ghiggi, Francesca Gaia Rossi, Annalisa Arcari, Fiorella Ilariucci, Vittorio Ruggero Zilioli, Leonardo Flenghi, Melania Celli, Stefano Volpetti, Fabio Benedetti, Filippo Ballerini, Gerardo Musuraca, Riccardo Bruna, Caterina Patti, Francesco Leonardi, Luca Arcaini, Massimo Magagnoli, Federica Cavallo, Valentina Tabanelli, Giovannino Ciccone, Stefano A Pileri, Paolo Corradini
Journal: Blood (2022)
A Phase II Study of the Combination of Decitabine, Venetoclax and Ponatinib in Patients with Chronic Myeloid Leukemia (CML) in Myeloid Blast Phase (MBP) or Philadelphia-Chromosome Positive (Ph+) Acute Myeloid Leukemia (AML)
Authors: Jayastu Senapati, Farhad Ravandi, Courtney D. DiNardo, Ghayas C. Issa, Koji Sasaki, Marina Konopleva, Naveen Pemmaraju, Kelly S. Chien, Maro Ohanian, Elias Jabbour, Abhishek Maiti, Edith Roy, Ricardo Delumpa, Juan Rivera, Christopher Loiselle, Glenda Banks, Hagop Kantarjian, Nicholas Short
Journal: Blood (2022)
Humanized T Cell Receptor-like Antibody Hu8F4 Reduces Leukemia By Fc-Mediated Mechanism
Authors: Anna Sergeeva, Hong He, Lisa St John, Celine Kerros, Ling Yu, Rolando A. Vedia, Valeria Rodriguez Gonzalez, Sijie Lu, Gheath Alatrash, Kathryn Cox, Karen Clise-Dwyer, Shao-Ping Yang, Gregory Lizee, Long Vien, Laura Bover, Qing Ma, Mithil Chokshi, Gang Bao, M. James You, Jeffrey J. Molldrem
Journal: Blood (2022)
26S Proteasome Non-Atpase Subunit 1, PSMD1/Rpn2, Is a Potential Therapeutic Target in Multiple Myeloma
Authors: Ting Du, Xueping Wan, Arghya Ray, Yao Yao, Ruben D. Carrasco, Mariateresa Fulciniti, Nikhil C Munshi, Dharminder Chauhan, Kenneth C. Anderson
Journal: Blood (2022)
Outcomes with Molecularly Targeted Agents As Salvage Therapy Following Frontline HMA/Venetoclax in Adults with Acute Myeloid Leukemia: A Multi-Center Retrospective Analysis
Authors: Vishesh Khanna, Tali Azenkot, Selina (Qiuying) Liu, Jason Gilbert, Edna Cheung, Kimberly Lau, Daniel A. Pollyea, Elie Traer, Brian A. Jonas, Tian Y. Zhang, Gabriel N. Mannis
Journal: Blood (2022)
Effect of Voxelotor on Red Blood Cell Adhesion Under Normoxia Using an Endothelialized Microfluidic System
Authors: Neha J. Desai, Chiara Federici, Aaron Wolfe, Zoe Sekyonda, Allison Bode, Amma Owusu-Ansah, Umut A. Gurkan
Journal: Blood (2022)
Circulating Tumor DNA Clearance during Treatment As a Predictive and Prognostic Biomarker for Diffuse Large B-Cell Lymphoma Patients Receiving First-Line Therapy
Authors: Yuqin Song, Miaomiao Li, Lan Mi, Chunyang Wang, Xiaojuan Wang, Jianhua Zhu, Fei Qi, Hui Yu, Yingying Ye, Dedao Wang, Jiaowu Cao, Dingyao Hu, Quanyu Yang, Dandan Zhao, Tonghui Ma, Jun Zhu
Journal: Blood (2022)
Inhibition of Both IRAK1 and IRAK4 Is Required for Complete Suppression of NF-Kb Signaling across Multiple Receptor-Mediated Pathways in MDS and AML
Authors: Jan S Rosenbaum, Scott B. Hoyt, Amal S. Kolt, Daniel A Luedtke, Craig J. Thomas, Daniel T. Starczynowski
Journal: Blood (2022)
Investigation of Impact Induced By AML1-ETO on Self-Renewal and Differentiation of Hematopoietic Stem and Progenitor Cells in Pre-Leukemic Stage
Authors: Xiaoyu Liu, Shaowei Qiu, Haiyan Xing, Runxia Gu, Junli Mou, Wanqing Xie, Zheng Tian, Kejing Tang, Qing Rao, Min Wang, Jianxiang Wang
Journal: Blood (2022)
The Investigation of Antitumor Effect of Humanized Bispecific BCMA/CD38 CAR-T Cells on Multiple Myeloma
Authors: Zhaoqi Chen, Yang Lu, Yingxi Xu, Shaowei Qiu, Runxia Gu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Dongsheng Xiong, Min Wang, Jianxiang Wang
Journal: Blood (2022)
Development of a Machine Learning Model Using Electrocardiogram Signals to Determine Acute Pulmonary Embolism
Authors: Ryan A. Meverden, Damon E. Houghton, Abraham Baez Suarez, Jose R. Medina Inojosa, Francisco Lopez-Jimenez, Ana I. Casanegra, Betsy J. Medina Inojosa, Itzhak Z. Attia, Paul A. Friedman, Waldemar E. Wysokinski
Journal: Blood (2022)
Quantitative Cytogenetic Analysis with <i>karyoParser</i> Allows for More Precise Identification of Disease Biology, Clonal Evolution, and Etiology of Relapse in Acute Myeloid Leukemia
Authors: Deepika Dilip, Andriy Derkach, Kamal Menghrajani, Aaron D Goldberg, Hannah May, Virginia M. Klimek, Pallavi K Galera, Wenbin Xiao, Yanming Zhang, Olivier Elemento, Ross L. Levine, Jacob L Glass
Journal: Blood (2022)
Frontline Treatment with Zanubrutinib Plus Rituximab (ZR) Followed By Short Course R-Dhaox Shows Potent Efficacy in Patients with Mantle Cell Lymphoma (MCL) - Preliminary Results of Phase II CHESS Clinical Trial
Authors: Qingqing Cai, Yi Xia, Panpan Liu, Yuchen Zhang, Huiqiang Huang, Yan Gao, Guowei Li, Xiuhua Sun, Xueyi Pan
Journal: Blood (2022)
<i>ASXL1</i> Mutations Are Associated with a Response to the Combination of Alvocidib and 5-Azacytidine in Higher-Risk Myelodysplastic Syndromes
Authors: Vladimir Riabov, Qingyu Xu, Nanni Schmitt, Alexander Streuer, Guo Ge, Johann-Christoph Jann, Alina Wein, Eva Altrock, Felicitas Rapp, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Melda Göl, Mark Wunderlich, Ahmed Jawhar, Ali Darwich, Patrick Wuchter, Christel Weiss, Jason M Foulks, Daniel T. Starczynowski, Feng-Chun Yang, Georgia Metzgeroth, Laurenz Steiner, Wolf-Karsten Hofmann, Daniel Nowak, Mohamad Jawhar
Journal: Blood (2022)
Tyrosine Kinase Inhibitors in the Treatment of Steroid Refractory Chronic Graft Versus Host Disease
Authors: Tabinda Saleem, Iuliia Kovalenko, Babray Laek, Rimsha Ali, Taaha Muddassir Mirza, Asmi Chattaraj, Ahsan Wahab, Asma Tameez, Hafiz Qurashi, Konstantin Golubykh, Martin Cuevas, Wern Lynn Ng, Yijin Wert, Rafiullah Khan
Journal: Blood (2022)
PHF6 Maintains Acute Myeloid Leukemia Via Regulating NF-Κappab Signaling Pathway
Authors: Xiaomin Wang, Shuaibing Hou, Tengxiao Guo, Yanjie Lan, Shengnan Yuan, Shuang Yang, Fei Zhao, Yajing Chu, Cheng Tao, Weiping Yuan
Journal: Blood (2022)
Multi-Modal Analysis and Federated Learning Approach for Classification and Personalized Prognostic Assessment in Myeloid Neoplasms
Authors: Saverio D'Amico, Lorenzo Dall'Olio, Cesare Rollo, Patricia Alonso, Iñigo Prada-Luengo, Daniele Dall'Olio, Claudia Sala, Matteo Bersanelli, Elisabetta Sauta, Marilena Bicchieri, Pierandrea Morandini, Tobia Tommasini, Victor Savevski, Lin-Pierre Zhao, Uwe Platzbecker, Maria Diez-Campelo, Valeria Santini, Pierre Fenaux, Torsten Haferlach, Anders Krogh, Santiago Zazo, Piero Fariselli, Tiziana Sanavia, Matteo G. Della Porta, Castellani Gastone
Journal: Blood (2022)
A Phase I/II Study of Combination of ASTX727, Gilteritinib and Venetoclax in Patients with Relapsed/Refractory <i>FLT3</i> Mutated Acute Myeloid Leukemia (AML) and Frontline <i>FLT3</i> Mutated AML Patients Unfit for Chemotherapy
Authors: Faustine Ong, Nicholas Short, Naval Daver, Tapan M. Kadia, Courtney D. DiNardo, Musa Yilmaz, Yesid Alvarado, Kenneth Vaughan, Sherry A. Pierce, Hagop Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi
Journal: Blood (2022)
Outcomes of Newly Diagnosed Therapy-Related AML and AML with Myelodysplasia-Related Changes Treated with 7+3, Hypomethylating Agents with or without Venetoclax and CPX-351: A Retrospective Cohort Study
Authors: Hanan Alharthy, Fahad Alkaabba, Matthew Williams, Elizabeth Corley, Kathryn A.F. Kline, Jennie Y. Law, Seung Tae Lee, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Moaath K. Mustafa Ali
Journal: Blood (2022)
Putative Predictors of Response to WU-NK-101, an Allogeneic, Enhanced Memory (ML) Natural Killer (NK) Cell Therapy Product, for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Authors: Sergio Rutella, Amanda F. Cashen, John Muth, Mary Elizabeth Mathyer, Alun James Carter, Brunda Tumala, Laura Arthur, Kristann Magee, Paula Comune Pennacchi, Julian Gorrochategui, Vincent Petit, Daniel Primo, Dominique Blanchard, Michael Kiebish, Nupur Bhatnagar, David Boocock, Jayakumar Vadakekolathu, Matthew L Cooper, Melissa M. Berrien-Elliott, Jan K Davidson-Moncada, Todd A. Fehniger
Journal: Blood (2022)
Synthetic Data Generation By Artificial Intelligence to Accelerate Translational Research and Precision Medicine in Hematological Malignancies
Authors: Saverio D'Amico, Elisabetta Sauta, Matteo Bersanelli, Daniele Dall'Olio, Claudia Sala, Lorenzo Dall'Olio, Pierandrea Morandini, Tobia Tommasini, Marilena Bicchieri, Matteo Zampini, Victor Savevski, Iñigo Prada-Luengo, Anders Krogh, Uwe Platzbecker, Maria Diez-Campelo, Valeria Santini, Pierre Fenaux, Torsten Haferlach, Castellani Gastone, Matteo G. Della Porta
Journal: Blood (2022)
Clonal Hematopoiesis in Vexas Syndrome
Authors: Bhavisha A. Patel, Fernanda Gutierrez-Rodrigues, Yael Kusne, Jenna A. Fernandez, Terra Lasho, Ruba Shalhoub, Xiaoyang Ma, Hugh Alessi, Christy Finke, Matthew Koster, Abhishek A. Mangaonkar, Kenneth Warrington, Kebede H. Begna, Zhuoer Xie, Amanda Ombrello, David S. Viswanatha, Marcela Ferrada, Lorena Wilson, Ronald Go, Taxiarchis Kourelis, Kaaren K. Reichard, Horatiu Olteanu, Emma M. Groarke, Ivana Darden, Dalton Hironaka, Sofia Rosenzweig, Daniel L. Kastner, Katherine R. Calvo, Colin O. Wu, Peter C. Grayson, David B. Beck, Mrinal M.M. Patnaik, Neal S. Young
Journal: Blood (2022)
Thrombotic Manifestations in Patients with Vexas Syndrome
Authors: Pedro E. Alcedo Andrade, Ruba Shalhoub, Alina Dulau-Florea, Khanh Nghiem, Marcela Ferrada, Lorena Wilson, Ivana Darden, Wendy Goodspeed, Katherine R. Calvo, David B. Beck, Daniel L. Kastner, Peter C. Grayson, Neal S. Young, Colin O. Wu, Yogendra Kanthi, Bhavisha A. Patel, Emma M. Groarke
Journal: Blood (2022)
Bcl-2 Family (Bcl-2, Mcl-1, Bim and Bax) and Btk Expression in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Lymphocytes in Different Lymphoid Compartments and Changes during Btk Inhibitor Therapies (ibrutinib or acalabrutinib)
Authors: Ozren Jaksic, Marija Ivic, Branimir Gizdic, Zdravko Mitrovic, Ena Soric, Ozana Jaksic, Anamarija Vrkljan Vuk, Mario Pirsic, Vlatko Pejsa, Branimir Jaksic, Rajko Kusec
Journal: Blood (2022)
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures
Authors: Bachisio Ziccheddu, Benjamin Diamond, Kylee H Maclachlan, Justin Taylor, Eileen M Boyle, Juan E. Arango Ossa, Jahn Jacob, Maurizio Affer, Tulasigeri M Totiger, David Coffey, Justin Watts, Sydney X. Lu, Niccolo Bolli, Kelly L Bolton, Jae H Park, Heather Landau, Karuna Ganesh, Andrew McPherson, Mikkael A. Sekeres, Alexander M Lesokhin, David J. Chung, Yanming Zhang, Caleb Ho, Mikhail Roshal, Jeffrey W. Tyner, Stephen D Nimer, Elli Papaemmanuil, Saad Usmani, Gareth J. Morgan, Ola Landgren, Francesco Maura
Journal: Blood (2022)
Metformin Inhibits STAT3 and MAPK Signaling through AMPK Activation in CSF3RT618I Cells
Authors: Natasha Peixoto Fonseca, Bruna Alves Fenerich, Diego A Pereira-Martins, Pedro Manoel Marques Garibaldi, Juan L Coelho-Silva, Antonio Bruno Alves Silva, Jaqueline Cristina Fernandes, Cleide Lucia Silva, Eduardo M Rego, João Agostinho Machado-Neto, Fabiola Traina
Journal: Blood (2022)
A Phase Ib Open-Label Study Evaluating the Safety and Efficacy of NKTR-255 in Combination with CD19-Directed CAR-T Cell Therapy in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Authors: Alexandre Vinaud Hirayama, Cassie Chou, David G. Maloney, Mario Q. Marcondes, Cameron J. Turtle
Journal: Blood (2022)
SHP-2 Regulates Myeloid Cell Differentiation, Anti-Tumor Responses and Innate Immune Memory
Authors: Anthos Christofides, Xanthi-Leda Katopodi, Carol Cao, Dimitra Karagkouni, Konstantinos Aliazis, Sasitorn Yenyuwadee, Rinku Pal, John Asara, Ioannis Vlachos, Nikolaos Patsoukis, Vassiliki A Boussiotis
Journal: Blood (2022)
Age-Related Immune Cell Dynamics Influences Outcomes after Allogeneic Hematopoietic Cell Transplantation
Authors: Jandin Alizee, Cecile Pochon, Arnaud Campidelli, Maud D'Aveni, Celine Kicki, Tshinguta Mbuyi, Marcelo De Carvalho Bittencourt, Pascal Chastagner, Pierre Feugier, Simona Pagliuca, Marie Thérèse Rubio
Journal: Blood (2022)
Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naïve (TN) Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)
Authors: Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Charles Herbaux, Damien Roos Weil, Alix Baugier de Materre, Xavier Roussel, Sabine Tricot, Jehan Dupuis, Ronan Le Calloch, Benoit Bareau, Marie C Béné, Veronique Leblond
Journal: Blood (2022)
Prospective Follow-up of Patients with Myelofibrosis (MF) and Treated with Ruxolitinib in France: The Rumycup Study
Authors: Jean-Jacques Kiladjian, Françoise Boyer perrard, Kamel Laribi, Jean-Christophe Ianotto, Dana Ranta, Omar Benbrahim, Serge Bologna, Pascale Cony-Makhoul, Alberto Santagostino, Hacene Zerazhi, Abla Slimani, Olivier Fitoussi, Gabriel Etienne
Journal: Blood (2022)
Final Results from the First-in-Human Phase 1/2 Study of Modakafusp Alfa, an Immune-Targeting Attenuated Cytokine, in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Dan T. Vogl, Shebli Atrash, Sarah A. Holstein, Omar Nadeem, Don M. Benson, Kaveri Suryanarayan, Yuyin Liu, Sabrina Collins, Xavier Parot, Jonathan L. Kaufman
Journal: Blood (2022)
Target Densities in Malignant and Normal Cells Determine CAR T Cell Efficacy and Off-Target Hematotoxicity
Authors: Sascha Haubner, Jorge Mansilla-Soto, Sarah Nataraj, Friederike Kogel, Qing Chang, Elisa De Stanchina, Kathryn Fraser, Jae H Park, Xiuyan Wang, Isabelle Rivière, Michel Sadelain
Journal: Blood (2022)
Thrombopoietin Levels Predict the Response to Avatrombopag Treatment in Patients with Persistent Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation
Authors: Haixia Fu, Meng Lv, Yuanyuan Zhang, Tingting Han, Xiao-Dong Mo, Fengrong Wang, Chenhua Yan, Jun Kong, Yu Wang, Yuqian Sun, Wei Han, Huan Chen, Yao Chen, Yu-Hong Chen, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang
Journal: Blood (2022)
Incidence of Central Nervous System Toxicity and Cytokine Release Syndrome in Leukemia Patients Treated with Blinatumomab
Authors: Elias Jabbour, Shilpa Paul, Dan E. Nichols, Faezeh Darbaniyan, Jenessa Lee, Koji Sasaki, Nicholas Short, Nitin Jain, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia, Guillermo Montalban-Bravo, Gautham Borthakur, Rebecca Garris, Marina Konopleva, Hagop Kantarjian
Journal: Blood (2022)
CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML
Authors: Nawid Albinger, Tobias Bexte, Leon Buchinger, Philipp Wendel, Ahmad Al-Ajami, Alec Gessner, Vinzenz Särchen, Jamal Alzubi, Sarah Mertlitz, Olaf Penack, Raj Bhayadia, Jan-Henning Klusmann, Meike Vogler, Nina Möker, Toni Cathomen, Michael A. Rieger, Katharina Imkeller, Evelyn Ullrich
Journal: Blood (2022)
CAR-T Prescriber Preferences in Adolescents and Young Adults with B-ALL
Authors: Richard Curtis Godby, Asmaa Ferdjallah, Hassan B. Alkhateeb, Victor Aquino, Michelle P. Hudspeth, Hemalatha G. Rangarajan, Carrie Lynn Kitko, Eric Jon Anderson, Susan Kelly, Arunkumar J. Modi, Emmanuel Katsanis, Shanti Ramachandran, Yi Lin, Mira A Kohorst
Journal: Blood (2022)
Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global Study
Authors: Matthew S. Davids, Asher Chanan-Khan, Boyd Mudenda, Larysa Nogaieva, Iryna Kriachok, Hanna Usenko, Vladimir Ivanov, Olena Kyselova, Tetiana Perekhrestenko, Ivan Muzhychuk, Alexander Myasnikov, Zvenyslava Maslyak, Andrew Proidakov, Olga Uspenskaya, Elena Borisenkova, Paula Marlton, Tanya Siddiqi, Allison Winter, Tamila Lysa, Bulat Bakirov, Lei Fu, Zi Chen, Min Yu, Mingyu Li, Laura Glass, Mohammad Ahmad, Olena Karpenko, Iurii Osipov, Asit De, Ben Paudyal, Hengbang Wang, Robert Winkler, Nashat Gabrail, Vinod Ganju, Tatiana S. Konstantinova, Olga S. Samoylova, Dajun Yang, Yifan Zhai
Journal: Blood (2022)
Erythroid and Megakaryocytic Differentiation Program in <i>JAK2</i>-Mutated Acute Myeloid Leukemia with or without Antecedent Myeloproliferative Neoplasm
Authors: Ying Liu, Shenon Sethi, Richard Koche, Qi Gao, Deepika Dilip, Jacob L Glass, Pallavi K Galera, Sonali Persaud, Tanmay Mishra, Xiaotian Sun, Dory Londono, Robert Cimera, Menglei Zhu, Christopher Famulare, Jeeyeon Baik, Himanshu Bhurtel, Maria E. Arcila, Ahmet Dogan, Ross L. Levine, Yanming Zhang, Mikhail Roshal, Raajit K Rampal, Wenbin Xiao
Journal: Blood (2022)
TET2-Mediated mRNA and DNA Oxidation in Leukemia Homing and Immune Evasion
Authors: Yangchan Li, Xiaolan Deng, Lei Dong, Li Han, Le Xuan Truong Nguyen, Jianhuang Xue, Zhicong Zhao, Wei Li, Ying Qing, Chao Shen, Brandon Tan, Zhenhua Chen, Meilin Xue, Keith Leung, Kitty Wang, Srividya Swaminathan, Ling Li, Mark Wunderlich, James C Mulloy, Bin Zhang, David A Horne, Steve T Rosen, Guido Marcucci, Mingjiang Xu, Zejuan Li, Minjie Wei, Rui Su, Jianjun Chen
Journal: Blood (2022)
Trial in Progress: An Open-Label, Multi-Center Phase 2 Study Evaluating Efficacy and Safety of the Masp-2 Inhibitor Narsoplimab in Pediatric Patients with High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA)
Authors: William Pullman, Mary Brough, Carolina Soto, Tze-Chiang Meng
Journal: Blood (2022)